CO50 Benefit and Risk of Oral Anticoagulant Initiation Strategies in Patients With Atrial Fibrillation and Cancer: A Target Trial Emulation Using the SEER-Medicare Database
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.139
https://www.valueinhealthjournal.com/article/S1098-3015(24)00254-7/fulltext
Title :
CO50 Benefit and Risk of Oral Anticoagulant Initiation Strategies in Patients With Atrial Fibrillation and Cancer: A Target Trial Emulation Using the SEER-Medicare Database
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00254-7&doi=10.1016/j.jval.2024.03.139
First page :
Section Title :
Open access? :
No
Section Order :
10770